Blood-Based Biomarkers Providing Clinical Information

• Main Authors: KIMYEONG, SHIM JUNG AE, KIM YEO JIN, JEON YEON SU, CHOI YEON SONG, JANG JIN HO, JEON SUNG WON, KIM SEUNG HOON, BHAK JONG HWA, LEE SE MIN, KIM CHANG JAE, KIM BYUNG CHUL, KIM BYOUNG CHUL, PARK SEUNG GU, HONG SEUL GI, KIM YEON KYUNG, JEONG HYOUNG OH, PARK YE SHIN, CHO YUN SUNG, BHAK YOUNG JUNE
• Format: Patent
• Language: English; Korean
• Published: 11.03.2021
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPIRITS; VINEGAR; WINE

A method of providing clinical information according to one aspect can effectively provide clinical information by including a step of detecting a genetic mutation. A composition according to one aspect can be effectively used to provide clinical information by including an agent for detecting a genetic mutation. A kit according to one aspect can be effectively used to provide clinical information by including the composition. 일 양태로서의 임상정보를 제공하는 방법은 유전자 변이를 검출하는 단계를 포함하여 효과적으로 임상정보를 제공할 수 있다. 일 양태로서의 조성물은 유전자 변이를 검출하는 제제를 포함하여 임상정보의 제공에 효과적으로 사용될 수 있다. 일 양태로서의 키트는 상기 조성물을 포함하여 임상정보의 제공에 효과적으로 사용될 수 있다.